资讯
Preliminary results from the CONNECT1 clinical trial showed a favorable safety profile along with increased exon skipping and dystrophin production. DALLAS—PGN-EDO51, an exon 51 skipping therapy for ...
The company’s shares rose by about 5% in early trading. Although small, the Phase 2 trial showed that a so-called exon-skipping therapy can result in “substantial improvements” in muscle health, Wave ...
The drug is an oligonucleotide being studied in boys with Duchenne muscular dystrophy (DMD) who are amenable to exon 53 skipping. The data, from 11 boys ages 5-11 with DMD—10 ambulatory and one ...
(RTTNews) - Entrada Therapeutics, Inc. (TRDA), on Monday announced that it has received authorization from the United Kingdom's Medicines and Healthcare Products Regulatory Agency or MHRA and ...
Exon skipping is based on instructing cells to "skip" these mutations during protein production, with the hope of restoring a functional protein. In 2024, the PMO franchise earned $967m of ...
Avidity Biosciences shared Monday that its RNA drug for people with certain mutations of Duchenne muscular dystrophy continued to show strong results as it com ...
Michelle Obama on Tuesday appeared to open up publicly for the first time about her decision to skip President Trump’s inauguration, saying she’s at the point in her life where she’s ...
Commissions do not affect our editors' opinions or evaluations. Project management software makes the lives of project managers, Scrum Masters and business owners easier. Its ability to help plan ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果